questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques 3 noyaux
Xanthènes
Xanthènes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cancer-Associated Fibroblasts
Diagnostic
5
Intoxication
Tests de laboratoire
Chromatographie
Analyse chimique
Analyse d'urine
Détection
Historique médical
Exposition
Symptômes
5
Réaction allergique
Allergies
Système nerveux
Convulsions
Chimie organique
Variabilité des symptômes
Irritation cutanée
Dermatologie
Prévention
5
Prévention
Équipements de protection
Formation professionnelle
Sécurité au travail
Sécurité en laboratoire
Équipements de protection
Réglementation
Santé publique
Sensibilisation
Éducation à la santé
Traitements
5
Intoxication
Soins médicaux
Anticonvulsivants
Neurologie
Soins de soutien
Toxicologie
Médecine alternative
Efficacité des traitements
Complications
5
Maladies chroniques
Exposition prolongée
Effets à long terme
Santé cognitive
Santé reproductive
Toxicologie
Suivi médical
Traitements symptomatiques
Facteurs de risque
5
Travailleurs
Industrie chimique
Antécédents médicaux
Maladies respiratoires
Habitudes de vie
Tabagisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Xanthènes : Questions médicales les plus fréquentes",
"headline": "Xanthènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Xanthènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Xanthènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérocycliques 3 noyaux",
"url": "https://questionsmedicales.fr/mesh/D006575",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérocycliques 3 noyaux",
"code": {
"@type": "MedicalCode",
"code": "D006575",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Propanthéline",
"alternateName": "Propantheline",
"url": "https://questionsmedicales.fr/mesh/D011413",
"about": {
"@type": "MedicalCondition",
"name": "Propanthéline",
"code": {
"@type": "MedicalCode",
"code": "D011413",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.558"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pyronine",
"alternateName": "Pyronine",
"url": "https://questionsmedicales.fr/mesh/D011754",
"about": {
"@type": "MedicalCondition",
"name": "Pyronine",
"code": {
"@type": "MedicalCode",
"code": "D011754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rhodamines",
"alternateName": "Rhodamines",
"url": "https://questionsmedicales.fr/mesh/D012235",
"about": {
"@type": "MedicalCondition",
"name": "Rhodamines",
"code": {
"@type": "MedicalCode",
"code": "D012235",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rhodamine 123",
"alternateName": "Rhodamine 123",
"url": "https://questionsmedicales.fr/mesh/D020112",
"about": {
"@type": "MedicalCondition",
"name": "Rhodamine 123",
"code": {
"@type": "MedicalCode",
"code": "D020112",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.600.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thioxanthènes",
"alternateName": "Thioxanthenes",
"url": "https://questionsmedicales.fr/mesh/D013892",
"about": {
"@type": "MedicalCondition",
"name": "Thioxanthènes",
"code": {
"@type": "MedicalCode",
"code": "D013892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.704"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chlorprothixène",
"alternateName": "Chlorprothixene",
"url": "https://questionsmedicales.fr/mesh/D002749",
"about": {
"@type": "MedicalCondition",
"name": "Chlorprothixène",
"code": {
"@type": "MedicalCode",
"code": "D002749",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.704.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clopenthixol",
"alternateName": "Clopenthixol",
"url": "https://questionsmedicales.fr/mesh/D003006",
"about": {
"@type": "MedicalCondition",
"name": "Clopenthixol",
"code": {
"@type": "MedicalCode",
"code": "D003006",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.704.269"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flupentixol",
"alternateName": "Flupenthixol",
"url": "https://questionsmedicales.fr/mesh/D005475",
"about": {
"@type": "MedicalCondition",
"name": "Flupentixol",
"code": {
"@type": "MedicalCode",
"code": "D005475",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.704.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hycanthone",
"alternateName": "Hycanthone",
"url": "https://questionsmedicales.fr/mesh/D006826",
"about": {
"@type": "MedicalCondition",
"name": "Hycanthone",
"code": {
"@type": "MedicalCode",
"code": "D006826",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.704.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tiotixène",
"alternateName": "Thiothixene",
"url": "https://questionsmedicales.fr/mesh/D013888",
"about": {
"@type": "MedicalCondition",
"name": "Tiotixène",
"code": {
"@type": "MedicalCode",
"code": "D013888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.704.787"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Xanthones",
"alternateName": "Xanthones",
"url": "https://questionsmedicales.fr/mesh/D044004",
"about": {
"@type": "MedicalCondition",
"name": "Xanthones",
"code": {
"@type": "MedicalCode",
"code": "D044004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.852"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lucanthone",
"alternateName": "Lucanthone",
"url": "https://questionsmedicales.fr/mesh/D008154",
"about": {
"@type": "MedicalCondition",
"name": "Lucanthone",
"code": {
"@type": "MedicalCode",
"code": "D008154",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.953.852.388"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Xanthènes",
"alternateName": "Xanthenes",
"code": {
"@type": "MedicalCode",
"code": "D014966",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hongji Li",
"url": "https://questionsmedicales.fr/author/Hongji%20Li",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China."
}
},
{
"@type": "Person",
"name": "Steven R Gwaltney",
"url": "https://questionsmedicales.fr/author/Steven%20R%20Gwaltney",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States."
}
},
{
"@type": "Person",
"name": "Colleen N Scott",
"url": "https://questionsmedicales.fr/author/Colleen%20N%20Scott",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States."
}
},
{
"@type": "Person",
"name": "Ramalingam Manivannan",
"url": "https://questionsmedicales.fr/author/Ramalingam%20Manivannan",
"affiliation": {
"@type": "Organization",
"name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea."
}
},
{
"@type": "Person",
"name": "Young-A Son",
"url": "https://questionsmedicales.fr/author/Young-A%20Son",
"affiliation": {
"@type": "Organization",
"name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea. yason@cnu.ac.kr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identification of cancer-associated fibroblasts subtypes in prostate cancer.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/37033924",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1133160"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer.",
"datePublished": "2022-10-16",
"url": "https://questionsmedicales.fr/article/36244987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05320-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37000314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10495-023-01828-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.",
"datePublished": "2022-10-25",
"url": "https://questionsmedicales.fr/article/36284087",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05351-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37170098",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12964-023-01093-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques 3 noyaux",
"item": "https://questionsmedicales.fr/mesh/D006575"
},
{
"@type": "ListItem",
"position": 5,
"name": "Xanthènes",
"item": "https://questionsmedicales.fr/mesh/D014966"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Xanthènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Xanthènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Xanthènes",
"description": "Comment diagnostiquer une intoxication aux xanthènes ?\nQuels tests sont utilisés pour détecter les xanthènes ?\nQuels symptômes indiquent une exposition aux xanthènes ?\nLes xanthènes peuvent-ils être détectés dans l'urine ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Cancer-Associated+Fibroblasts#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Xanthènes",
"description": "Quels sont les symptômes courants d'une exposition aux xanthènes ?\nLes xanthènes provoquent-ils des réactions allergiques ?\nComment les xanthènes affectent-ils le système nerveux ?\nLes symptômes varient-ils selon le type de xanthène ?\nLes xanthènes affectent-ils la peau ?",
"url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Cancer-Associated+Fibroblasts#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Xanthènes",
"description": "Comment prévenir l'exposition aux xanthènes ?\nLes travailleurs doivent-ils être formés sur les xanthènes ?\nQuelles mesures de sécurité doivent être prises en laboratoire ?\nLes xanthènes sont-ils réglementés ?\nComment informer le public sur les dangers des xanthènes ?",
"url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Cancer-Associated+Fibroblasts#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Xanthènes",
"description": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?\nDes antidotes existent-ils pour les xanthènes ?\nComment traiter les symptômes neurologiques causés par les xanthènes ?\nLes soins de soutien sont-ils nécessaires ?\nPeut-on utiliser des traitements naturels contre les xanthènes ?",
"url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Cancer-Associated+Fibroblasts#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Xanthènes",
"description": "Quelles complications peuvent survenir après une exposition aux xanthènes ?\nLes xanthènes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des xanthènes ?\nLes xanthènes peuvent-ils affecter la reproduction ?\nComment gérer les complications liées aux xanthènes ?",
"url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Cancer-Associated+Fibroblasts#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Xanthènes",
"description": "Qui est le plus à risque d'exposition aux xanthènes ?\nLes enfants sont-ils plus vulnérables aux xanthènes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes antécédents médicaux influencent-ils le risque ?\nLes habitudes de vie jouent-elles un rôle dans le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Cancer-Associated+Fibroblasts#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux xanthènes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les xanthènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses chromatographiques comme la HPLC sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux xanthènes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les xanthènes peuvent-ils être détectés dans l'urine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests urinaires peuvent révéler la présence de xanthènes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique aide à identifier les expositions antérieures aux xanthènes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition aux xanthènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les xanthènes provoquent-ils des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques aux xanthènes."
}
},
{
"@type": "Question",
"name": "Comment les xanthènes affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles neurologiques comme des convulsions ou des tremblements."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de xanthène ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la structure chimique des xanthènes."
}
},
{
"@type": "Question",
"name": "Les xanthènes affectent-ils la peau ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition cutanée peut entraîner des irritations ou des éruptions."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux xanthènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les produits contenant des xanthènes et portez des équipements de protection."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les xanthènes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être prises en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les xanthènes sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée pour protéger la santé publique."
}
},
{
"@type": "Question",
"name": "Comment informer le public sur les dangers des xanthènes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes de sensibilisation et des brochures d'information peuvent être utiles."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les xanthènes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les xanthènes."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques causés par les xanthènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anticonvulsivants peuvent être utilisés pour gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les soins de soutien sont-ils nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien sont souvent nécessaires pour les cas graves."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des traitements naturels contre les xanthènes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de preuves solides pour des traitements naturels efficaces."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition aux xanthènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et dermatologiques peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les xanthènes peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des xanthènes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les xanthènes peuvent-ils affecter la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux xanthènes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements symptomatiques sont recommandés."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux xanthènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et les laboratoires sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables aux xanthènes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des xanthènes."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution et l'exposition à des produits chimiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie jouent-elles un rôle dans le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme peuvent augmenter la vulnérabilité aux xanthènes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China.
Publications dans "Xanthènes" :
3 publications dans cette catégorie
Affiliations :
Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Publications dans "Xanthènes" :
3 publications dans cette catégorie
Affiliations :
Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Publications dans "Xanthènes" :
3 publications dans cette catégorie
Affiliations :
Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea.
Publications dans "Xanthènes" :
3 publications dans cette catégorie
Affiliations :
Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea. yason@cnu.ac.kr.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Virginia, Charlottesville, VA, 22904, USA.
University of Virgnia Cancer Center, University of Virginia, Charlottesville, VA, 22904, USA.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Berkeley, CA, 94720, USA. evanwmiller@berkeley.edu.
Department of Molecular & Cell Biology, University of California, Berkeley, CA, 94720, USA.
Helen Wills Neuroscience Institute, University of California, Berkeley, CA, 94720, USA.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, State Key Laboratory of Bioactive Substance and Function of Natural Medicines & Beijing Key Laboratory of Active Substances Discovery and Drugability Evaluation, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China.
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin 541004, P. R. China.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Virginia, Charlottesville, VA, USA.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Masaryk University Faculty of Science: Masarykova univerzita Prirodovedecka Fakulta, Department of Chemistry, Kamenice 5, 62500, Brno, CZECH REPUBLIC.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
Publications dans "Xanthènes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, Bonn, Germany.
Publications dans "Xanthènes" :
Cancer-associated fibroblasts (CAFs) are one of the most abundant cell types in tumor microenvironment. However, the phenotypic and functional heterogeneities among CAFs have not been sufficiently inv...
We obtained and analyzed the single-cell RNA-sequencing data from 26 hormone-sensitive prostate cancer samples and 8 castration-resistant prostate cancer samples, along with the analysis of bulk-seque...
We identified two major CAFs subtypes with distinct molecular characteristics and biological functions in prostate cancer microenvironment, namely αSMA+ CAV1+ CAFs-C0 and FN1+ FAP+ CAFs-C1. Another si...
In summary, our results identified the presence of heterogeneous CAFs subtypes in prostate cancer microenvironment and the potential of specific CAFs subtype as therapeutic target for castration-resis...
Despite advances in anticancer therapy, the prognosis of gastric cancer (GC) remains unsatisfactory. Research in recent years has shown that the malignant behavior of cancer is not only attributable t...
Dysregulation of autophagy in cancer-associated fibroblasts (CAFs) has been demonstrated to play a role in malignant phenotypes of human tumors. We intended to investigate the function of CAFs autopha...
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a prominent extracellular matrix (ECM) deposition and poor prognosis. High levels of ECM proteins derived from tumour cells reduce the e...
The primary goal of radiotherapy (RT) is to induce cellular damage on malignant cells; however, it is becoming increasingly recognized the important role played by the tumor microenvironment (TME) in ...
Cancer-associated fibroblasts (CAFs) are known to participate in all stages of cancer progression and are increasingly acknowledged to contribute to therapy resistance. Accumulated evidence suggests t...
In this review we present current knowledge on the field of CAFs role in radiotherapy; we discuss the potential tumorigenic functions of radiation-induced senescent fibroblasts and CAFs and we make an...
Papillary thyroid carcinoma (PTC) has a relatively good prognosis, yet there are some invasive PTC cases with worse clinicopathological features and poor outcome. Cancer-associated fibroblasts (CAFs) ...
Primary liver cancer (PLC) includes hepatocellular carcinoma and intrahepatic cholangiocarcinoma and is the sixth most common cancer worldwide with poor prognosis. PLC is characterized by an abundant ...
Cancer-associated fibroblasts (CAFs) are central players in the microenvironment of solid tumors, affecting cancer progression and metastasis. CAFs have diverse phenotypes, origins and functions and c...
The characteristics of a tumor are largely determined by its interaction with the surrounding micro-environment (TME). TME consists of both cellular and non-cellular components. Cancer-associated fibr...
Fibroblasts have been derived from Benign Prostatic Hyperplasia (BPH) and prostate cancer. RNA from these has been used to perform a transcriptome analysis in order to get a comparative profile of nor...
The study has identified 818 differentially expressed mRNAs and 17 lincRNAs between normal and cancer-associated fibroblasts. Also, 15 potential lincRNA-miRNA-mRNA combinations have been identified wh...
This study identified differentially expressed markers between normal and cancer-associated fibroblasts that would help in targeted therapy against CAFs/derived factors, in combination with convention...
The tumor microenvironment is one of the important drivers of tumor development. Cancer-associated fibroblasts (CAFs) are a major component of the tumor stroma and actively participate in tumor develo...